Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Unravelling Genetic Mechanisms of Erythrocytosis: A Real-Life Experience from a Single Center

Carmelo Gurnari, MD, Annamaria Lombardi, Elisabetta Cosi, Giacomo Biagetti, Francesco Buccisano, MD, Luca Franceschini, MD, PhD, Manuela Rizzo, MD, Ambra Di Veroli, MD, Luca Maurillo, MD, PhD, Giulia Falconi, PhD, Emiliano Fabiani, PhD, Maria Cantonetti, MD, Ida Provenzano, Daniela Nasso, Francesco Lo-Coco, MD, Maria Luigia Randi, MD, Maria Teresa Voso

Blood (2018) 132 (Supplement 1): 3617.

https://doi.org/10.1182/blood-2018-99-115103

Published: 2018

Journal Articles

Response to Erythropoietin in Different Karyotipic Subsets of Myelodysplastic Syndromes (MDS) and MDS with Sideroblasts: Multicentric Real-Life Experience from the Grom-L Cooperative Group

Blood (2017) 130 (Supplement 1): 4262.

https://doi.org/10.1182/blood.V130.Suppl_1.4262.4262

Published: 2017

Journal Articles

Longitudinal Detection of DNMT3A R882H Transcripts in Patients with Acute Myeloid Leukemia

Blood (2017) 130 (Supplement 1): 3959.

https://doi.org/10.1182/blood.V130.Suppl_1.3959.3959

Published: 2017

Journal Articles

Identification of Relapse Risk Using a Multiparameter Flow Cytometry-Based Detection of Minimal Residual Disease in Adult Patients with Acute Myeloid Leukemia at ELN Intermediate-Risk

Marco Chiarini, MSc, Viviana Giustini, MSc, Francesco Buccisano, MD, Erika Borlenghi, MD, Mirko Farina, MD, Chiara Cattaneo, MD, Diego Bertoli, MSc, Federico Serana, MD PhD, Alessandro Montanelli, MD, Luisa Imberti, MD, Aldo M. Roccaro, Maria Ilaria Del Principe, Luca Maurillo, MD, PhD, Adriano Venditti, MD, Giuseppe Rossi, MD

Blood (2017) 130 (Supplement 1): 2697.

https://doi.org/10.1182/blood.V130.Suppl_1.2697.2697

Published: 2017

Journal Articles

Primary Myelofibrosis in Younger Patients: A Retrospective Analysis of the Gruppo Laziale MPN Ph-Negative

Massimo Breccia, MD PhD, Ambra Di Veroli, Marianna De Muro, MD, Malgorzata Monika Trawinska, Sabrina Crescenzi Leonetti, MD, Michele Cedrone, MD, Luca Petriccione, MD, Atelda Romano, Ada D'Addosio, MD, Matteo Molica, MD, Antonia Centra, MD, Raffaele Porrini, MD, Stefano Felici, MD, Luca Maurillo, MD, PhD, Marco Montanaro, MD, Alessandro Andriani, MD, Pasquale Niscola, MD, Robin Foa, MD, Roberto Latagliata

Blood (2017) 130 (Supplement 1): 5274.

https://doi.org/10.1182/blood.V130.Suppl_1.5274.5274

Published: 2017

Journal Articles

Incidence of Early Adverse Events in Primary Myelofibrosis (PMI). a Prospective Analysis from the Gruppo Laziale of Ph-Negative MPN

Blood (2017) 130 (Supplement 1): 5276.

https://doi.org/10.1182/blood.V130.Suppl_1.5276.5276

Published: 2017

Journal Articles

Pattern of Central Nervous System (CNS) Involvement in Adult Acute Myeloid Leukemia (AML) and Its Impact on Outcome

Blood (2016) 128 (22): 2789.

https://doi.org/10.1182/blood.V128.22.2789.2789

Published: 2016

Journal Articles

Incidence of Early Thrombosis in Myeloproliferative Neoplasms (MPN): A Prospective Analysis from the Gruppo Laziale of Ph-Negative MPN

Blood (2016) 128 (22): 1951.

https://doi.org/10.1182/blood.V128.22.1951.1951

Published: 2016

Journal Articles

Low Bax/Bcl-2 Ratio and NOTCH1 Mutations Represent Powerful and Synergistic Adverse Prognostic Factors within Trisomy 12 Chronic Lymphocytic Leukemia (CLL)

Giovanni Del Poeta, MD, Maria Ilaria Del Principe, MD, Massimiliano Postorino, Michele Dal Bo, Maria Francesca Rossi, Francesco Buccisano, Luca Maurillo, MD, Davide Rossi, Livio Pupo, Benedetta Mariotti, Adriano Venditti, MD, Paolo de Fabritiis, MD, Maria Cantonetti, Gianluca Gaidano, Francesco Lo Coco, MD, Valter Gattei, Sergio Amadori, MD

Blood (2016) 128 (22): 3204.

https://doi.org/10.1182/blood.V128.22.3204.3204

Published: 2016

Journal Articles

Azacitidine in Older Patients with Acute Myeloid Leukemia (AML). Results from the Expanded International E-Alma Series (E-ALMA+) According to the MRC Risk Index Score

Blood (2015) 126 (23): 2554.

https://doi.org/10.1182/blood.V126.23.2554.2554

Published: 2015

Journal Articles

Cost Description on a Cohort of 659 Patients with Adult MDS Included into the Italian Lazio Region Registry (the GROM-L)

Carlo Lazzaro, Dr., Maria Antonietta Aloe-Spiriti, MD, Maria Teresa Voso, MD, Roberto Latagliata, MD, Francesco Buccisano, MD, Susanna Fenu, MD, Luca Maurillo, MD, Roberto Ricci, Dr., Luana Fianchi, Gina Zini, MD Prof.

Blood (2015) 126 (23): 5237.

https://doi.org/10.1182/blood.V126.23.5237.5237

Published: 2015

Journal Articles

Variable Outcome of Allogeneic Stem Cell Transplant According to the Different Levels of Pre-Transplant Minimal Residual Disease, in Adult Patients with Acute Myeloid Leukemia

Francesco Buccisano, MD, Luca Maurillo, MD, Alfonso Piciocchi, Maria Ilaria Del Principe, MD, Gottardo De Angelis, MD, Ambra Di Veroli, MD, Raffaella Cerretti, MD, Mariagiovanna Cefalo, MD, Concetta Ditto, MD, Alessandra Picardi, MD, Laura Cudillo, MD, Benedetta Mariotti, MD, Francesco Lo Coco, MD, William Arcese, MD, Sergio Amadori, MD, Adriano Venditti, MD

Blood (2015) 126 (23): 3230.

https://doi.org/10.1182/blood.V126.23.3230.3230

Published: 2015

Journal Articles

MEN1112/OBT357, an Anti Bst1/CD157 Humanized Antibody Inducing Acute Myelogenous Leukemia (AML) Blast Depletion in an Autologous Ex Vivo Assay: A Potential New Targeted Therapy for AML

Adriano Venditti, MD, Francesco Buccisano, Luca Maurillo, MD, Maria Ilaria Del Principe, MD, Andrea Coppola, Patrizia Palomba, Roberto Arriga, Daniela Bellarosa, Alessandro Bressan, Keith Wilson, Stefano Manzini, Angela Capriati, MD PhD, Cecilia Simonelli, MD, Monica Binaschi, Sergio Amadori, MD, Giuseppe Sconocchia

Blood (2015) 126 (23): 788.

https://doi.org/10.1182/blood.V126.23.788.788

Published: 2015

Journal Articles

Clinical Significance of Apoptosis in Chronic Lymphocytic Leukemia (CLL)

Giovanni Del Poeta, Maria Ilaria Del Principe, MD, Michele Dal Bo, Francesco Buccisano, MD, Dario Ragusa, Federico Pozzo, Pietro Bulian, Luca Maurillo, MD, Davide Rossi, MD PhD, Adriano Venditti, Paolo de Fabritiis, MD, Gianluca Gaidano, Sergio Amadori, Valter Gattei

Blood (2014) 124 (21): 834.

https://doi.org/10.1182/blood.V124.21.834.834

Published: 2014

Journal Articles

Bendamustine Improves Clinical Outcome in Chronic Lymphocytic Leukemia (CLL) According to Different Clinical and Biological Prognostic Factors

Giovanni Del Poeta, Maria Ilaria Del Principe, MD, Dario Ragusa, Pietro Bulian, Francesco Buccisano, MD, Francesca Maria Rossi, Alessio Pio Perrotti, Luca Maurillo, MD, Paolo de Fabritiis, MD, Valter Gattei, Sergio Amadori, MD

Blood (2014) 124 (21): 5668.

https://doi.org/10.1182/blood.V124.21.5668.5668

Published: 2014

Journal Articles

Allogeneic but Not Autologous Stem Cell Transplant Attenuates the Negative Prognostic Impact Dictated By Pretransplant MRD Positivity

Francesco Buccisano, MD, Luca Maurillo, MD, Maria Ilaria Del Principe, Gottardo De Angelis, MD, Raffaella Cerretti, MD, Concetta Ditto, MD, Ambra Di Veroli, MD, Alessandra Picardi, MD, Laura Cudillo, MD, Mariagiovanna Cefalo, MD, Chiara Sarlo, MD, Giorgia Fedele, MD, Marco Refrigeri, MD, Francesco Lo Coco, MD, William Arcese, MD, Sergio Amadori, Adriano Venditti

Blood (2014) 124 (21): 2363.

https://doi.org/10.1182/blood.V124.21.2363.2363

Published: 2014

Journal Articles

Therapy-Related Myeloid Neoplasms: Report Of The Italian Network On Secondary Leukemias

Blood (2013) 122 (21): 2659.

https://doi.org/10.1182/blood.V122.21.2659.2659

Published: 2013

Journal Articles

Real-Life Efficacy Of Azacitidine In Myelodysplastic Syndromes According To IPSS Cytogenetic Profile

Massimo Breccia, Maria Teresa Voso, M.D., Luca Maurillo, MD, Pasquale Niscola, Luana Fianchi, MD, Maria Antonietta Aloe Spiriti, Francesco Buccisano, Sabrina Pelliccia, Susanna Fenu, Andrea Tendas, Roberto Latagliata, MD, Giuliana Alimena

Blood (2013) 122 (21): 5229.

https://doi.org/10.1182/blood.V122.21.5229.5229

Published: 2013

Journal Articles

Age-Stratified Analysis Of The Prognostic Role Of Minimal Residual Disease Detection By Flow Cytometry, In Adult Patients With Acute Myeloid Leukemia

Francesco Buccisano, MD, Luca Maurillo, MD, Alfonso Piciocchi, PhD, Maria Ilaria Del Principe, MD, Chiara Sarlo, MD, Mariagiovanna Cefalo, MD, Concetta Ditto, MD, Ambra Di Veroli, MD, Daniela Nasso, MD, Marco Refrigeri, MD, Maria Antonietta Irno Consalvo, PhD, Daniela Fraboni, PhD, Consuelo Conti, Giovanni Del Poeta, MD, Francesco Lo Coco, MD, Sergio Amadori, Adriano Venditti, MD

Blood (2013) 122 (21): 2649.

https://doi.org/10.1182/blood.V122.21.2649.2649

Published: 2013

Journal Articles

Prognostic Factors Associated To Achievement Of Complete Or Partial Response In MDS Patients Treated With Azacitidine Outside Clinical Trials

Massimo Breccia, Maria Teresa Voso, M.D., Luca Maurillo, MD, Pasquale Niscola, Francesco Autore, MD, Maria Antonietta Aloe Spiriti, Francesco Buccisano, MD, Caterina Tatarelli, Andrea Tendas, Susanna Fenu, Roberto Latagliata, MD, Giuliana Alimena

Blood (2013) 122 (21): 5203.

https://doi.org/10.1182/blood.V122.21.5203.5203

Published: 2013

NARROW

Unravelling Genetic Mechanisms of Erythrocytosis: A Real-Life Experience from a Single Center

Response to Erythropoietin in Different Karyotipic Subsets of Myelodysplastic Syndromes (MDS) and MDS with Sideroblasts: Multicentric Real-Life Experience from the Grom-L Cooperative Group

Longitudinal Detection of DNMT3A R882H Transcripts in Patients with Acute Myeloid Leukemia

Identification of Relapse Risk Using a Multiparameter Flow Cytometry-Based Detection of Minimal Residual Disease in Adult Patients with Acute Myeloid Leukemia at ELN Intermediate-Risk

Primary Myelofibrosis in Younger Patients: A Retrospective Analysis of the Gruppo Laziale MPN Ph-Negative

Incidence of Early Adverse Events in Primary Myelofibrosis (PMI). a Prospective Analysis from the Gruppo Laziale of Ph-Negative MPN

Pattern of Central Nervous System (CNS) Involvement in Adult Acute Myeloid Leukemia (AML) and Its Impact on Outcome

Incidence of Early Thrombosis in Myeloproliferative Neoplasms (MPN): A Prospective Analysis from the Gruppo Laziale of Ph-Negative MPN

Low Bax/Bcl-2 Ratio and NOTCH1 Mutations Represent Powerful and Synergistic Adverse Prognostic Factors within Trisomy 12 Chronic Lymphocytic Leukemia (CLL)

Azacitidine in Older Patients with Acute Myeloid Leukemia (AML). Results from the Expanded International E-Alma Series (E-ALMA+) According to the MRC Risk Index Score

Cost Description on a Cohort of 659 Patients with Adult MDS Included into the Italian Lazio Region Registry (the GROM-L)

Variable Outcome of Allogeneic Stem Cell Transplant According to the Different Levels of Pre-Transplant Minimal Residual Disease, in Adult Patients with Acute Myeloid Leukemia

MEN1112/OBT357, an Anti Bst1/CD157 Humanized Antibody Inducing Acute Myelogenous Leukemia (AML) Blast Depletion in an Autologous Ex Vivo Assay: A Potential New Targeted Therapy for AML

Clinical Significance of Apoptosis in Chronic Lymphocytic Leukemia (CLL)

Bendamustine Improves Clinical Outcome in Chronic Lymphocytic Leukemia (CLL) According to Different Clinical and Biological Prognostic Factors

Allogeneic but Not Autologous Stem Cell Transplant Attenuates the Negative Prognostic Impact Dictated By Pretransplant MRD Positivity

Therapy-Related Myeloid Neoplasms: Report Of The Italian Network On Secondary Leukemias

Real-Life Efficacy Of Azacitidine In Myelodysplastic Syndromes According To IPSS Cytogenetic Profile

Age-Stratified Analysis Of The Prognostic Role Of Minimal Residual Disease Detection By Flow Cytometry, In Adult Patients With Acute Myeloid Leukemia

Prognostic Factors Associated To Achievement Of Complete Or Partial Response In MDS Patients Treated With Azacitidine Outside Clinical Trials

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only